Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  AstraZeneca plc    AZN   GB0009895292

ASTRAZENECA PLC

 (AZN)
25
Delayed Quote. Delayed London Stock Exchange - 05/17 11:35:25 am
3383 GBp   -0.19%
4d ago ANALYSIS - BLACKSTONE AND PEERS HAVE: themselves
5d ago Dish lines up banks to finance Sprint bid - sources
05/10 Drugmakers face more scrutiny of discordant U.S. prices
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
3338(c) 3342.5(c) 3374.5(c) 3389.5(c) 3383(c) Last
1 367 264 1 621 675 2 198 823 1 670 061 2 121 350 Volume
-0.13% +0.13% +0.96% +0.44% -0.19% Change
More quotes
Company
AstraZeneca is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows: - cardiovascular diseases (34%); - gastrointestinal diseases (17.3%): No. 1 worldwide for drugs used to treat ulcers; - respiratory and inflammatory diseases (15.8%); -... 
Read more
Sector
Pharmaceuticals - Generic / Specialty
Calendar
06/01 | 03:15pmPresentation
Surperformance© rating of AstraZeneca plc
Trading Rating : Investor Rating :
More about the company
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca plc Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 26 238 M
EBIT 2013 7 825 M
Net income 2013 5 065 M
Debt 2013 290 M
Yield 2013 5,47%
Sales 2014 25 459 M
EBIT 2014 7 699 M
Net income 2014 5 319 M
Finance 2014 1 623 M
Yield 2014 5,55%
PER 2013 13,10
PER 2014 12,69
EV / Sales 2013 2,47x
EV / Sales 2014 2,48x
Capitalization 64 637 M
More Financials
Latest news on ASTRAZENECA PLC
4d ago ANALYSIS - BLACKSTONE AND PEERS HAVE: themselves
5d ago Dish lines up banks to finance Sprint bid - sources
05/10 Drugmakers face more scrutiny of discordant U.S. prices
05/10DJBT Boosted by Broadband Investment
05/06DJU.S. HOT STOCK FUTURES: Hot stocks to watch
05/06DJBRISTOL-MYERS, ASTRAZENECA: Study Shows Metreleptin May Treat Pediatric Lipodys..
05/06 ASTRAZENECA PLC: Sub-Group Analysis Shows Investigational Metreleptin Treatment..
05/02DJSanofi Forecasts Second-Half Growth
05/02DJSanofi Sees Second-Half Growth
04/25DJEUROPE MARKETS: Europe Stocks Rise As U.K. Avoids Recession
04/25DJLONDON MARKETS: U.K. Stocks Rise As GDP Data Beat Views
04/25DJEUROPE MARKETS: Europe Stocks Rise As U.K. Avoids Recession
More news
Forum ASTRAZENECA PLC
Be the first to post a message on ASTRAZENECA PLC
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
AstraZeneca plc : Income Statement Evolution
More Financials
EPS Revisions
AstraZeneca plc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.